Targeting the Oxytocin System: New Pharmacotherapeutic Approaches. (January 2019)
- Record Type:
- Journal Article
- Title:
- Targeting the Oxytocin System: New Pharmacotherapeutic Approaches. (January 2019)
- Main Title:
- Targeting the Oxytocin System: New Pharmacotherapeutic Approaches
- Authors:
- Gulliver, Damien
Werry, Eryn
Reekie, Tristan A.
Katte, Timothy A.
Jorgensen, William
Kassiou, Michael - Abstract:
- Abstract : Deficits in social behavioral domains, such as interpersonal communication, emotion recognition, and empathy, are a characteristic symptom in several neuropsychiatric disorders, including schizophrenia and autism spectrum disorder (ASD). The neuropeptide oxytocin (OT) has emerged as a key regulator of diverse social behaviors in vertebrates and, thus, has been identified as a potential therapeutic target for improving social dysfunction. In recent years, the field of OT research has seen an explosion of scientific inquiry, producing a more comprehensive picture of oxytocinergic signaling and the pathways that regulate its release and degradation in the brain. In this review, we provide an analysis of how this information is being exploited to accelerate the discovery of novel oxytocinergic therapeutics. Highlights: The OT system is involved in the regulation of social behavior, and has been identified as a therapeutic target in neuropsychiatric disorders characterized by deficits in social behavior. The neurobiological basis of oxytocinergic actions is now being elucidated, creating unprecedented opportunities for developing therapeutics that modulate OT signaling. Novel ligands targeting the OT receptor display functional bias and exploit receptor dimerization, opening a range of potential investigative and therapeutic avenues. Emerging strategies that potentiate endogenous OT signaling could also provide a new and advantageous approach to modulate socialAbstract : Deficits in social behavioral domains, such as interpersonal communication, emotion recognition, and empathy, are a characteristic symptom in several neuropsychiatric disorders, including schizophrenia and autism spectrum disorder (ASD). The neuropeptide oxytocin (OT) has emerged as a key regulator of diverse social behaviors in vertebrates and, thus, has been identified as a potential therapeutic target for improving social dysfunction. In recent years, the field of OT research has seen an explosion of scientific inquiry, producing a more comprehensive picture of oxytocinergic signaling and the pathways that regulate its release and degradation in the brain. In this review, we provide an analysis of how this information is being exploited to accelerate the discovery of novel oxytocinergic therapeutics. Highlights: The OT system is involved in the regulation of social behavior, and has been identified as a therapeutic target in neuropsychiatric disorders characterized by deficits in social behavior. The neurobiological basis of oxytocinergic actions is now being elucidated, creating unprecedented opportunities for developing therapeutics that modulate OT signaling. Novel ligands targeting the OT receptor display functional bias and exploit receptor dimerization, opening a range of potential investigative and therapeutic avenues. Emerging strategies that potentiate endogenous OT signaling could also provide a new and advantageous approach to modulate social behavior. … (more)
- Is Part Of:
- Trends in pharmacological sciences. Volume 40:Number 1(2019)
- Journal:
- Trends in pharmacological sciences
- Issue:
- Volume 40:Number 1(2019)
- Issue Display:
- Volume 40, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 40
- Issue:
- 1
- Issue Sort Value:
- 2019-0040-0001-0000
- Page Start:
- 22
- Page End:
- 37
- Publication Date:
- 2019-01
- Subjects:
- oxytocin -- drug development -- neuropsychiatric disease -- social cognition
Pharmacology -- Periodicals
Pharmacology -- trends -- Periodicals
Pharmacologie -- Périodiques
Pharmacology
Electronic journals
Periodicals
615.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01656147 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01656147 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01656147 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tips.2018.11.001 ↗
- Languages:
- English
- ISSNs:
- 0165-6147
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9049.675000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9267.xml